Free Trial

FARMERS & MERCHANTS TRUST Co OF LONG BEACH Acquires 7,750 Shares of Procter & Gamble Company (The) $PG

Procter & Gamble logo with Consumer Staples background

Key Points

  • Farmers & Merchants Trust Co of Long Beach increased its stake in Procter & Gamble by 40.3% in the second quarter, now owning 26,997 shares worth approximately $4.3 million.
  • Analysts have set a consensus target price of $173.68 for Procter & Gamble, with a mix of ratings that include one Strong Buy, eleven Buys, and eight Holds.
  • Procter & Gamble reported earnings of $1.48 per share in its latest quarter, exceeding the consensus estimate by $0.06, with a year-over-year revenue increase of 1.7% to $20.89 billion.
  • MarketBeat previews top five stocks to own in October.

FARMERS & MERCHANTS TRUST Co OF LONG BEACH boosted its holdings in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 40.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 26,997 shares of the company's stock after buying an additional 7,750 shares during the quarter. Procter & Gamble makes up about 0.9% of FARMERS & MERCHANTS TRUST Co OF LONG BEACH's investment portfolio, making the stock its 26th largest holding. FARMERS & MERCHANTS TRUST Co OF LONG BEACH's holdings in Procter & Gamble were worth $4,301,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in the business. Kingstone Capital Partners Texas LLC grew its position in Procter & Gamble by 655,209.0% during the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company's stock valued at $11,832,680,000 after buying an additional 76,017,350 shares during the period. Northern Trust Corp grew its position in Procter & Gamble by 0.8% during the first quarter. Northern Trust Corp now owns 29,644,000 shares of the company's stock valued at $5,051,930,000 after buying an additional 248,792 shares during the period. Price T Rowe Associates Inc. MD grew its position in Procter & Gamble by 13.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock valued at $3,660,737,000 after buying an additional 2,466,308 shares during the period. Goldman Sachs Group Inc. grew its position in Procter & Gamble by 3.5% during the first quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company's stock valued at $2,966,252,000 after buying an additional 583,629 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in Procter & Gamble by 6.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company's stock valued at $2,947,146,000 after purchasing an additional 1,018,865 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities analysts have weighed in on the stock. BNP Paribas Exane lowered their price target on shares of Procter & Gamble from $177.00 to $172.00 and set an "outperform" rating on the stock in a report on Tuesday, September 23rd. Barclays set a $164.00 price target on shares of Procter & Gamble and gave the company an "equal weight" rating in a report on Thursday, July 31st. BNP Paribas reaffirmed an "outperform" rating and set a $177.00 price target on shares of Procter & Gamble in a report on Friday, August 15th. Wells Fargo & Company lowered their price target on shares of Procter & Gamble from $173.00 to $170.00 and set an "overweight" rating on the stock in a report on Thursday. Finally, UBS Group set a $180.00 price target on shares of Procter & Gamble and gave the company a "buy" rating in a report on Wednesday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and eight have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $173.68.

Check Out Our Latest Stock Analysis on PG

Procter & Gamble Price Performance

PG stock opened at $152.44 on Monday. Procter & Gamble Company has a one year low of $149.91 and a one year high of $180.43. The company's fifty day moving average price is $156.00 and its 200-day moving average price is $160.49. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. The company has a market capitalization of $356.78 billion, a PE ratio of 23.42, a price-to-earnings-growth ratio of 4.02 and a beta of 0.36.

Procter & Gamble (NYSE:PG - Get Free Report) last released its earnings results on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, topping the consensus estimate of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The firm had revenue of $20.89 billion for the quarter, compared to the consensus estimate of $20.79 billion. During the same quarter in the previous year, the firm earned $1.40 earnings per share. The company's quarterly revenue was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, equities analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were paid a dividend of $1.0568 per share. The ex-dividend date of this dividend was Friday, July 18th. This represents a $4.23 dividend on an annualized basis and a yield of 2.8%. Procter & Gamble's dividend payout ratio is presently 64.98%.

Insider Activity at Procter & Gamble

In related news, CEO Gary A. Coombe sold 10,194 shares of the company's stock in a transaction on Thursday, August 21st. The shares were sold at an average price of $158.16, for a total transaction of $1,612,283.04. Following the sale, the chief executive officer owned 34,978 shares of the company's stock, valued at $5,532,120.48. This represents a 22.57% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Sundar G. Raman sold 9,554 shares of the company's stock in a transaction on Thursday, August 21st. The shares were sold at an average price of $158.16, for a total transaction of $1,511,060.64. Following the sale, the chief executive officer directly owned 41,886 shares in the company, valued at approximately $6,624,689.76. The trade was a 18.57% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 120,181 shares of company stock valued at $18,918,012 over the last quarter. 0.20% of the stock is currently owned by insiders.

Procter & Gamble Company Profile

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Read More

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Best & Worst Stocks in the Market Right Now
October Slowdown? 5 Signs to Watch Now
America Is Rebuilding — 3 Stocks Set to Soar

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines